Metabolic Risks Are Increasing in Non-B Non-C Early-Stage Hepatocellular Carcinoma: A 10-Year Follow-Up Study

BACKGROUND: Non-B, non-C hepatocellular carcinoma (NBNC-HCC) may be related to metabolic syndrome, and the incidence of this tumor type is increasing annually. The definition of metabolic-associated fatty liver disease (MAFLD) proposed in 2020 may help to more accuratelyassess the association betwee...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Yen-Po, Wang, Pei-Ming, Chuang, Ching-Hui, Yong, Chee-Chen, Liu, Yueh-Wei, Huang, Pao-Yuan, Yao, Chih-Chien, Tsai, Ming-Chao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8848276/
https://www.ncbi.nlm.nih.gov/pubmed/35186751
http://dx.doi.org/10.3389/fonc.2022.816472

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8848276/
https://www.ncbi.nlm.nih.gov/pubmed/35186751
http://dx.doi.org/10.3389/fonc.2022.816472

Ejemplares similares